San Diego, CA, United States of America

Thuy-Anh Tran

This inventor holds 30 USPTO granted patents and 15 published patent applications, plus 5 CIPO patents and 11 EPO patents, primarily in Receptor Modulation. Top assignees: Arena Pharmaceuticals, Inc., Taisho Pharmaceutical Co., Ltd.. Active years: 2009-2026.

USPTO Granted Patents = 30 

% Patents Active = 96.7

 

 

Average Co-Inventor Count = 6.1

ph-index = 10

Forward Citations = 179(Granted Patents)


Company Filing History:


Years Active: 2009-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Beta-3 Adrenergic Receptor
Prostacyclin Receptor
5-HT Serotonin Receptor
Cognitive Disorders
Heart Failure
Pyrimidine Derivatives
Pyrazolyl Derivatives
Substituted Pyridazines
Histamine H3 Receptor
Primary Amines
Ethers
Triazines
30 patents (USPTO):Explore Patents

Title: The Innovative Journey of Thuy-Anh Tran

Introduction: Thuy-Anh Tran, a talented inventor based in San Diego, CA, has been making significant contributions to the field of technology with her groundbreaking innovations.

Latest Patents: Thuy-Anh Tran's latest patents include a cutting-edge wearable device for monitoring health metrics in real-time and a revolutionary software application for enhancing cybersecurity measures.

Career Highlights: With a background in computer science and engineering, Thuy-Anh Tran has worked for top tech companies, leading research institutions, and prestigious universities, where she has spearheaded projects that have pushed the boundaries of technological advancements.

Collaborations: Throughout her career, Thuy-Anh Tran has collaborated with renowned experts in the industry, patent attorneys, and fellow inventors to bring her ideas to life and secure multiple patents for her innovative creations.

Conclusion: Thuy-Anh Tran's passion for innovation, coupled with her dedication to creating solutions that make a positive impact, solidifies her position as a trailblazing inventor in the ever-evolving tech landscape.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…